Target intelligence / Profile preview

Translin-associated protein X (TSNAX)

Target
TSNAX
Molecular classification
Other
01

Overview

Translin-associated protein X (TSNAX), also known as TRAX or C3PO, is a multifunctional protein encoded by the *TSNAX* gene in humans. TSNAX interacts with translin to form a heteromeric RNase complex—known as C3PO—that is involved in the degradation of microRNAs and activation of the RNA-induced silencing complex (RISC), processes essential for post-transcriptional gene regulation. In addition to a central role in synaptic plasticity through the relief of microRNA-mediated translational silencing, TSNAX also functions independently from translin in the nucleus as a cofactor for the ataxia-telangiectasia mutated (ATM) kinase, where it promotes DNA repair in response to double-stranded DNA breaks. It contains bipartite nuclear localization signals and may facilitate the nuclear import of its partner translin, which lacks such sequences. TSNAX has also been implicated in neuropsychiatric conditions (such as schizophrenia) and disorders of DNA repair. No approved drugs directly target TSNAX, nor are there specific safety or biomarker associations presently established[1][2][3][6].

Other names
Translin associated factor XTRAXC3POtranslin-like proteinTSNAXtranslin-associated protein Xtranslin associated factor X
02

Biological functions

RNA-induced silencing complex (RISC) activationmicroRNA degradationsynaptic plasticityDNA repair (ATM pathway)nuclear transport
03

Disease associations

SchizophreniaFanconi anemia, complementation group UOther (implicated in neuropsychiatric, chromosomal translocation-related, and DNA repair disorders)

Beyond the preview

Go deeper on Translin-associated protein X (TSNAX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Translin-associated protein X (TSNAX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call